OHSU Knight Cancer Institute: Neoplasms trials

The registry lists 23 Neoplasms studies with OHSU Knight Cancer Institute as lead sponsor. 3 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 4Phase 2 8Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES TrialNot yet recruitingNCT07606313Not applicable
• Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
• Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other DisordersAvailableNCT03626285
• Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell TransplantCompletedNCT03097588Phase 2Results posted
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide TherapyCompletedNCT02099864Phase 2Results posted
• DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain TumorsCompletedNCT00978562Early Phase 1Results posted
• Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedNCT00659126Phase 2Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00245037Phase 1/2Results posted
• Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral MetastasesCompletedNCT00103038Not applicableResults posted
• Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related SymptomsCompletedNCT05793957Not applicable
• Virtual Reality Experiences for Anxiety and Pain ControlCompletedNCT04759183Not applicable
• Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last YearWithdrawnNCT04455958Phase 2
• Virtual Reality for the Education of Cancer Patients Undergoing Radiation TherapyTerminatedNCT04278534Not applicable
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation TherapyCompletedNCT03677531Phase 1
• CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersCompletedNCT02355262
• Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)CompletedNCT01635413Not applicable
• Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell TumorsStatus unknownNCT00983398Phase 1/2
• Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
• Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaCompletedNCT00900055
• Tissue Sample Collection From Patients With Fanconi AnemiaCompletedNCT00899522
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3